Fulmz
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Fulmz - overview
Established
2015
Location
Guangzhou, Guangdong, China
Primary Industry
Healthcare IT
About
Based in Guangzhou, China and established in 2015, Fulmz operates as a biotechnology company that focuses on application of artificial intelligence technology. Daiguo Deng is the CEO and founder of the company. The company completed angel funding in December 2018. The company raised approximately CNY 100 million series A funding from Panda capital, Tongsheng capital in May 2020.
The company provides AI pharmaceutical platform. The company focuses on central nervous system (CNS), autoimmunity and refractory tumors fields. The company adopts AI drug molecular design, AI virtual screening, AI Prediction of ADMET and AI retrosynthetic analysis technologies. The company's product includes drug design platform - Fulmz Drug Studio.
The company also provides contract research organization (CRO) services. The company's pipeline includes best-in-class (BIC) and first-in-class (FIC), including FZ002, FZ008 project. In July 2022, the company will plan to invest in clinical trial, researching and development of product pipeline, constructing platform and team.
Current Investors
Panda Capital, Challenjers Venture, Jinkong Fund Management
Primary Industry
Healthcare IT
Sub Industries
Biopharmaceuticals, Healthcare IT, Pharmaceutical Research & Development
Website
www.fulmz.com
Verticals
Artificial Intelligence, Big Data, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Fulmz - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.